Updated: January 17, 2026
Alternatives to Voquezna If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- What Is Voquezna and Why Was It Prescribed?
- Alternatives for GERD and Erosive Esophagitis
- Omeprazole (Prilosec)
- Esomeprazole (Nexium)
- Lansoprazole (Prevacid)
- Pantoprazole (Protonix)
- Dexlansoprazole (Dexilant)
- Alternatives for H. Pylori Treatment
- How Do These Alternatives Compare to Voquezna?
- Should You Switch, or Keep Trying to Find Voquezna?
- Talk to Your Doctor First
Can't get Voquezna filled? Here are the best alternative medications for GERD, erosive esophagitis, and H. pylori — with comparisons to vonoprazan.
Voquezna (vonoprazan) is a first-in-class medication for GERD, erosive esophagitis, and H. pylori infections — but it's not always easy to access. The drug is brand-name only, with a high cash price and limited stocking at many retail pharmacies. If your pharmacy can't fill your Voquezna prescription, here's a clear, clinical look at your alternatives.
Always discuss any medication changes with your prescriber. This guide is informational, not medical advice.
What Is Voquezna and Why Was It Prescribed?
Vonoprazan is a potassium-competitive acid blocker (PCAB) — the first of its kind approved in the U.S. It's prescribed for: healing and maintenance of erosive esophagitis, heartburn relief in non-erosive GERD, and eradication of H. pylori (as Voquezna Triple Pak or Dual Pak). Clinical trials showed it was superior to lansoprazole for healing severe erosive esophagitis (Grade C/D), which is why some patients are prescribed it specifically.
Alternatives for GERD and Erosive Esophagitis
Proton pump inhibitors (PPIs) are the most established alternatives to Voquezna for GERD and erosive esophagitis. They've been in use for decades, are widely available as generics, and cost a fraction of Voquezna's price.
Omeprazole (Prilosec)
Omeprazole is the most widely prescribed PPI in the U.S. It's available OTC and as a generic prescription. Typical dose for erosive esophagitis is 20–40 mg once daily for 4–8 weeks. Generic omeprazole costs roughly $5–$15 per month, making it dramatically more affordable than Voquezna. It's appropriate for mild-to-moderate GERD and most cases of erosive esophagitis, though clinical data suggests vonoprazan may be more effective for the most severe cases.
Esomeprazole (Nexium)
Esomeprazole is the S-enantiomer of omeprazole and generally considered a potent PPI. Available OTC (20 mg) and as prescription (40 mg). Generic versions are available and cost roughly $10–$30 per month. In a network meta-analysis of PPIs vs. vonoprazan for erosive esophagitis, esomeprazole ranked among the better-performing PPIs (second only to ilaprazole, which isn't available in the U.S.).
Lansoprazole (Prevacid)
Lansoprazole is the direct comparison drug used in Voquezna's pivotal clinical trial (PHALCON-EE). Voquezna healed erosive esophagitis in 92.9% of patients vs. 84.6% for lansoprazole at 8 weeks. So lansoprazole is a reasonable alternative but may be less effective for severe disease. Generic lansoprazole costs ~$5–$15/month.
Pantoprazole (Protonix)
Pantoprazole is prescription-only and widely used in hospital and outpatient settings. Generic is available at ~$10–$25/month. It's a solid option for most patients with GERD or erosive esophagitis.
Dexlansoprazole (Dexilant)
Dexlansoprazole uses a dual-release formula that provides extended acid suppression — which can be particularly helpful for nighttime GERD symptoms. It's available as brand name Dexilant with some generic options. Cost is higher than basic PPIs but lower than Voquezna. Good choice if nighttime heartburn is a major complaint.
Alternatives for H. Pylori Treatment
If you were prescribed Voquezna Triple Pak or Voquezna Dual Pak for H. pylori, here are the established alternatives:
Standard triple therapy (PPI + amoxicillin + clarithromycin): The long-standing first-line H. pylori regimen. Uses lansoprazole or omeprazole instead of vonoprazan. Less expensive but slightly lower eradication rates in clarithromycin-resistant strains.
Bismuth quadruple therapy (Pylera or PPI + bismuth + metronidazole + tetracycline): Recommended when clarithromycin resistance is suspected. Pylera is a combination capsule; still requires a PPI.
Concomitant therapy (PPI + clarithromycin + amoxicillin + metronidazole): Four drugs given simultaneously for 10–14 days. Used in areas with high resistance.
How Do These Alternatives Compare to Voquezna?
Voquezna has two key advantages over PPIs: it works without requiring food to activate it, and it provides faster and more durable acid suppression. For mild-to-moderate GERD, the difference may be minimal. For severe erosive esophagitis (Grade C/D), the gap is more significant — Voquezna reduced treatment failure by 11–21% compared to PPIs in one major 2024 meta-analysis.
Another key difference: PPIs are significantly cheaper. Generic omeprazole or lansoprazole might cost $5–$15/month, while Voquezna (without savings) can run $830+ per month cash. For most commercially insured patients using the Voquezna Savings Card, the cost drops to $25.
Should You Switch, or Keep Trying to Find Voquezna?
That depends on why Voquezna was prescribed. If it was prescribed because PPIs failed or because you have severe erosive esophagitis, it's worth the extra effort to locate Voquezna before switching. Tools like medfinder and BlinkRx can help (see our guide: How to Find Voquezna In Stock Near You). But if your condition is mild-to-moderate and Voquezna was prescribed as a first-line option, a generic PPI may be an equally effective and much more affordable bridge while you work out the access issues.
Talk to Your Doctor First
Before switching medications, always contact your prescriber. Explain that you're having difficulty filling Voquezna and ask whether a PPI bridge is appropriate, or whether they can help facilitate access through BlinkRx or prior authorization. Never stop acid suppression abruptly, especially if you have erosive esophagitis, as rebound acid hypersecretion can occur.
Frequently Asked Questions
The best alternatives to Voquezna (vonoprazan) for GERD are proton pump inhibitors (PPIs) like omeprazole, esomeprazole, lansoprazole, or pantoprazole. These are widely available as generics at $5–$30/month. For mild-to-moderate GERD, PPIs perform similarly. For severe erosive esophagitis, vonoprazan has shown superior outcomes in clinical trials.
For most patients with mild-to-moderate GERD, generic omeprazole is comparable in effectiveness to Voquezna and dramatically cheaper. However, clinical trials show Voquezna (vonoprazan) has superior healing rates for severe erosive esophagitis (Grade C/D) — so for patients with serious disease, Voquezna may be clinically preferable.
Standard PPI-based triple therapy (PPI + amoxicillin + clarithromycin) is the most common alternative to Voquezna Triple Pak for H. pylori. Bismuth quadruple therapy (Pylera) is another option, especially when clarithromycin resistance is suspected. Voquezna-based regimens may have higher eradication rates against resistant H. pylori strains.
OTC antacids (Tums, Rolaids) provide quick but short-term relief and are not adequate alternatives for treating erosive esophagitis or H. pylori. OTC PPIs like omeprazole 20 mg (Prilosec OTC) may bridge mild GERD symptoms short-term, but prescription-strength therapy is needed for erosive esophagitis and H. pylori eradication.
Voquezna (vonoprazan) is a potassium-competitive acid blocker (PCAB), which blocks acid production by competing with potassium ions — unlike PPIs, which irreversibly bind the proton pump and require acid activation. This means Voquezna works whether you take it with or without food, has faster onset, and provides more durable acid suppression, especially for severe disease.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Voquezna also looked for:
More about Voquezna
30,237 have already found their meds with Medfinder.
Start your search today.





